By Joanne Kamens
Read More
Scientists need fast access to the tools required to study SARS-CoV-2, but with many academic research labs closed during the pandemic, it’s hard to get these reagents. However, when reagents have been made available through a repository, they remain accessible during these ...
This post was contributed by Max W. Shen from MIT, Alvin Hsu Harvard University, and David R. Liu from the Broad Institute and Harvard University. Over the course of the last six months, COVID-19 has had a tremendous impact on our world -- as of June 4, 2020, COVID-19 has caused ...
By Susanna Bachle and Matt Takvorian When COVID-19 researchers started working with us to help them share their reagents, we knew our role in fighting the pandemic could be even more impactful by reaching more scientists. Many members of the scientific community support open ...
Nanobodies from camelids have gotten a lot of press for being a promising approach for treatment or prophylaxis of COVID-19. Researchers identified nanobodies that bind to coronavirus spike proteins (Wrapp et al., 2020), which sit on the surface of coronaviruses and enable the ...
By Will Arnold and Shreya Vedantam Accelerating research by improving the availability of materials is a core part of our mission. In no situation is this more true than the current global pandemic in which scientists race to find vaccines, therapeutics, and other treatments to ...
As the world has battled the COVID-19 pandemic over the past few months, the scientific community has seen a shift towards prioritizing research into this disease. A key reason this research has been able to progress so rapidly is scientific sharing. Already we’ve seen articles ...
This post was contributed by Shravanti Suresh from Iowa State University. Since its appearance, SARS-CoV-2 has spread to almost every part of the world manifesting as a full-fledged pandemic. Containing the spread of this virus has become an utmost priority for countries around ...
